NCT02704338View on ClinicalTrials.gov

Safety and Efficacy Study of Regulatory T Cells in Treating Autoimmune Hepatitis

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

October 31, 2018

Conditions
Autoimmune Diseases
Interventions
BIOLOGICAL

Regulatory T cells

Regulatory t cells will be injected back to autoimmune hepatitis patients

Sponsors
All Listed Sponsors
lead

Nanjing Medical University

OTHER